Objective: To evaluate if clinical and laboratory parameters could assist in the differential diagnosis of intra and extra-hepatic neonatal cholestasis (NC).
Introduction
Neonatal cholestasis (NC) is a syndrome that poses a major diagnostic challenge to the clinician from an anatomical standpoint. A rapid investigation is always considered to be pathologically necessary. [1] [2] [3] The frequency of NC in the population is difficult to evaluate. Incidences of 1/2,500, 4 1/5,000, 5 and 1/9,000 6 live births have been recorded in the literature. The focus of the initial approach is to differentiate between intrahepatic (IHC) and extrahepatic (EHC) cholestasis. Differentiation between IHC and EHC may have a success rate of 90 to 95% when various diagnostic methods are used. 2 IHC represents about 2/3 of all cases of NC. 4, [7] [8] [9] Once established that cholestasis is intrahepatic, the new challenge is to determine the etiological diagnosis. In a classification proposed by Dellert & Balistreri, 8 of unknown etiology. The causes of EHC are less numerous and include biliary atresia (BA), choledochal cyst, biliary sludge, and biliary duct stricture. 1, 10 According to the guideline of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), any infant noted to be jaundiced at 2 weeks of age (or 3 weeks of age in those who are breastfed)
should be investigated for cholestasis by measuring serum bilirubin levels. 2 Treatable disorders, such as sepsis, hypothyroidism, panhypopituitarism, and inborn errors of metabolism (for example, galactosemia), must be recognized and treated promptly to prevent significant progression of the disease. In BA, urgency in diagnosis is associated with the performance of the Kasai porto-jejunostomy before the infant is 60 days of age and is directly related to successful treatment. 2, 9, 12, 13 The most important findings in BA are jaundice and acholic stools starting between ages 4 and 8 weeks in infants who are otherwise apparently in good health. 14 For early identification of BA cases, the use of a stool color card, 3, 15 ultrasonography for the presence of the triangular cord sign, 16, 17 and also correlation of clinical, laboratory and histopathological findings have been proposed. 3, 14, [18] [19] [20] This study is aimed at evaluating whether clinical and laboratory parameters may help to establish differentiation between IHC and EHC. Patients were divided into two groups: group I with IHC and group II with EHC.
Methods

Ethical aspects
The study was approved by the Research Ethics
Committee of the School of Medicine of UNICAMP.
Statistical analysis
To compare categorical variables between groups of patients with cholestasis, the chi-square test or Fisher's exact test was used, whenever necessary. To compare numerical variables between groups, the Mann-Whitney test was used. Due to the age difference between the groups, comparisons were repeated and corrected for age, using analysis of covariance (ANCOVA).
Receiver operating characteristic curve (ROC) analysis was carried out to obtain cutoff values for GGT (absolute values and number of times the upper limit of normal) to distinguish between IHC and EHC, using the final diagnosis as the gold standard.
Results
One hundred and sixty-eight patients were evaluated (group I = 54.8% and group II = 45.2%). A significant difference was observed between the groups regarding the following variables: gender, age, birth weight, height at birth, dark urine, acholic stools, hepatomegaly, direct bilirubin, absolute value and number of times the upper limit of normal for GGT.
The predominant gender was male (62.64%) in group I and female in group II (55.26%) with p = 0.026.
In infants investigated before 60 days of age, intrahepatic causes predominated, whereas in those investigated after 60 days of age, extrahepatic causes predominated (p < 0.001).
Weight and length at birth were lower in group I. Number of patients with birth weight lower than 2,500 g was higher in group I. Hepatomegaly, pale/acholic stools, and dark urine predominated in cases of EHC. Results are shown in Table   1 . The median serum level of direct bilirubin was higher in group II (p = 0.006). The same occurred with GGT level which was shown as the number of times the upper limit of normal (p < 0.001) ( Table 2 ). For the diagnosis of EHC, serum levels of gammaglutamyl-transferase ≥ 429.5 U/L or > 10.8 times the upper limit of normal had a sensitivity of 56.3%, a specificity of 91.5%, and an accuracy of 75.7% (Figures 1 and 2 ).
There were no statistical differences between groups I and II concerning history of fetal distress, breastfeeding, history of jaundice at birth or after the first month of life, vomiting, splenomegaly, presence of edema, and ascites.
Discussion
In the investigation of neonatal cholestasis, the main aim is to make an early diagnosis and promptly implement the most appropriate therapy. For example, cases of sepsis, hypothyroidism, and metabolic disease require early diagnosis and treatment to prevent progression of the disease and its consequent worsening. BA must be diagnosed promptly because early performance of the Kasai procedure (before 2 months of age) is directly related to successful therapy. 2 Liver biopsy is an excellent diagnostic test, as long as it contains five to seven portal tracts and is performed by an experienced pathologist with expertise in pediatric blood pathology. However, the gold standard of diagnosis is exploratory laparotomy. 2, 11, 21 Despite their help in differentiating intrahepatic from No statistically significant differences were found in serum levels of AST, ALT and AP, similar to results obtained in the present study.
Weight and length at birth were lower in the IHC group, possibly reflecting prematurity, failure to thrive, neonatal complications, metabolic disorders, and congenital infections. 8, 14, 19, 22, 23 The median age of infants at the time of referral is a cause for concern. In the EHC group, age at referral was over 60 days (77 days) of life and higher than that in the IHC group. Data published in Brazil show that in the majority of cases (76 to 94.7%), the diagnosis of BA is made after 8 weeks of life. 10, [24] [25] [26] [27] It is likely that infants in the IHC group were more promptly investigated, due to a more severe systemic illness and arrived earlier at a referral center. In the EHC group, referral was delayed, resulting in the performance of the Kasai portoenterostomy at a later date. Perhaps this may have contributed to a more frequent finding of hepatomegaly.
Dark urine and pale/acholic stools predominated in infants with EHC, and the median serum levels of direct bilirubin was higher, reflecting a more marked clinical picture of cholestasis.
GGT is an enzyme that transfers the gamma-glutamyl group from glutathione and other peptides. It is present in the biliary epithelium and hepatocytes. GGT levels are elevated in various liver diseases. GGT is also present in the kidney, breast, intestine, brain, pancreas, and spleen. Normal values vary with age, gender, and diagnostic methods. That is why emphasis is placed on results expressed as the number of times the upper limit of normal. 28 It is recognized as a useful test for differentiating familial cholestatic syndromes. 8 The use of GGT to differentiate IHC from EHC was not recommended by Moyer et al., 2 who classified it as level C evidence, because a wide variability of tests makes the interpretation of results more difficult.
Wright & Christie 29 reported that GGT > 300 UI/L could be suggestive of EHC. Lai et al. 17 found GGT values > 300 UI/L with a specificity of 82.8% and accuracy of 72% for the diagnosis of EHC. Wang et al. 30 concluded that normal or low levels of serum GGT may indicate a more severe case of idiopathic IHC, albeit reversible.
In the present study, the GGT value expressed as the number of times the upper limit of normal was also higher in cases of EHC.
Using a GGT cutoff value > 203.5 UI/L or 5. 
